Guangdong Jiaying Pharmaceutical Co.,Ltd.’s Net Profit Rose 380.6% in First Quarter of 2023
Listen to the full version

Guangdong Jiaying Pharmaceutical Co.,Ltd. (广东嘉应制药股份有限公司) (002198.SZ) reported a net profit of 12.2 million yuan in the first quarter of 2023, up 380.6% year-on-year.
Meanwhile, the company posted 128.5 million yuan in revenue, up 6.6% year-on-year.
At the end of the reporting period, it had 831.2 million yuan in total assets and 90.6 million yuan in total liabilities, with a liability-to-asset ratio of 10.9%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR